1至8批国家集采药品接续采购开标;阿斯利康去年全球总营收达587.39亿美元丨医药早参

每日经济新闻
Feb 11

丨2026年2月11日星期三丨  NO.1 1至8批国家集采药品接续采购开标  据央视新闻2月10日报道,记者从国家医保局获悉,1至8批国家集采药品新一轮接续采购开标产生拟中选结果,涉及316种常用药品,1020家企业的4163个产品获得拟中选资格。本次接续采购的药品覆盖抗感染、抗肿瘤、降血糖、降血压、降血脂、神经系统、呼吸系统、消化系统等26个治疗领域。  点评:本轮接续采购在组织形式和规则层面...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10